Lepu Medical Tech Beijing (300003) - Total Assets
Based on the latest financial reports, Lepu Medical Tech Beijing (300003) holds total assets worth CN¥25.59 Billion CNY (≈ $3.74 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore how well can Lepu Medical Tech Beijing service its debt to assess how comfortably operating cash covers total debt obligations.
Lepu Medical Tech Beijing - Total Assets Trend (2006–2025)
This chart illustrates how Lepu Medical Tech Beijing's total assets have evolved over time, based on quarterly financial data. See 300003 book value for net asset value and shareholders' equity analysis.
Lepu Medical Tech Beijing - Asset Composition Analysis
Current Asset Composition (December 2025)
Lepu Medical Tech Beijing's total assets of CN¥25.59 Billion consist of 38.2% current assets and 61.8% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 17.0% |
| Accounts Receivable | CN¥1.99 Billion | 7.6% |
| Inventory | CN¥2.02 Billion | 7.7% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥3.09 Billion | 11.8% |
| Goodwill | CN¥3.62 Billion | 13.9% |
Asset Composition Trend (2006–2025)
This chart illustrates how Lepu Medical Tech Beijing's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Lepu Medical Tech Beijing.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Lepu Medical Tech Beijing's current assets represent 38.2% of total assets in 2025, a decrease from 70.4% in 2006.
- Cash Position: Cash and equivalents constituted 17.0% of total assets in 2025, down from 30.3% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 24.0% of total assets, an increase from 5.0% in 2006.
- Asset Diversification: The largest asset category is goodwill at 13.9% of total assets.
Lepu Medical Tech Beijing Competitors by Total Assets
Key competitors of Lepu Medical Tech Beijing based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Novocure Ltd
NASDAQ:NVCR
|
USA | $787.93 Million |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Bactiguard Holding AB (publ)
ST:BACTI-B
|
Sweden | Skr537.34 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
Lepu Medical Tech Beijing - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.38 | 1.82 | 2.27 |
| Quick Ratio | 1.88 | 1.42 | 1.80 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥5.35 Billion | CN¥4.05 Billion | CN¥5.17 Billion |
Lepu Medical Tech Beijing - Advanced Valuation Insights
This section examines the relationship between Lepu Medical Tech Beijing's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.62 |
| Latest Market Cap to Assets Ratio | 0.13 |
| Asset Growth Rate (YoY) | 6.4% |
| Total Assets | CN¥26.14 Billion |
| Market Capitalization | $3.49 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Lepu Medical Tech Beijing's assets below their book value (0.13x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Lepu Medical Tech Beijing's assets grew by 6.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Lepu Medical Tech Beijing (2006–2025)
The table below shows the annual total assets of Lepu Medical Tech Beijing from 2006 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥26.14 Billion ≈ $3.82 Billion |
+6.37% |
| 2024-12-31 | CN¥24.57 Billion ≈ $3.60 Billion |
-1.80% |
| 2023-12-31 | CN¥25.02 Billion ≈ $3.66 Billion |
+2.19% |
| 2022-12-31 | CN¥24.48 Billion ≈ $3.58 Billion |
+18.29% |
| 2021-12-31 | CN¥20.70 Billion ≈ $3.03 Billion |
+13.38% |
| 2020-12-31 | CN¥18.26 Billion ≈ $2.67 Billion |
+14.63% |
| 2019-12-31 | CN¥15.93 Billion ≈ $2.33 Billion |
+5.46% |
| 2018-12-31 | CN¥15.10 Billion ≈ $2.21 Billion |
+18.06% |
| 2017-12-31 | CN¥12.79 Billion ≈ $1.87 Billion |
+34.63% |
| 2016-12-31 | CN¥9.50 Billion ≈ $1.39 Billion |
+22.91% |
| 2015-12-31 | CN¥7.73 Billion ≈ $1.13 Billion |
+101.83% |
| 2014-12-31 | CN¥3.83 Billion ≈ $560.44 Million |
+22.43% |
| 2013-12-31 | CN¥3.13 Billion ≈ $457.76 Million |
+13.75% |
| 2012-12-31 | CN¥2.75 Billion ≈ $402.44 Million |
+12.58% |
| 2011-12-31 | CN¥2.44 Billion ≈ $357.46 Million |
+9.70% |
| 2010-12-31 | CN¥2.23 Billion ≈ $325.84 Million |
+20.03% |
| 2009-12-31 | CN¥1.86 Billion ≈ $271.47 Million |
+204.51% |
| 2008-12-31 | CN¥609.24 Million ≈ $89.15 Million |
+34.95% |
| 2007-12-31 | CN¥451.47 Million ≈ $66.06 Million |
+153.77% |
| 2006-12-31 | CN¥177.91 Million ≈ $26.03 Million |
-- |
About Lepu Medical Tech Beijing
Lepu Medical Technology (Beijing) Co., Ltd., together with its subsidiaries, engages in the research, development, and manufacturing of cardiac interventional medical devices in China and internationally. The company operates through three segments: Medical Devices; Pharmaceuticals; and Medical Services and Health Management. It offers medical devices, including cardiovascular devices, in vitro d… Read more